1 2652 140 YOGA IMPROVES MITOCHONDRIAL HEALTH AND REDUCES SEVERITY OF AUTOIMMUNE INFLAMMATORY ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: OXIDATIVE STRESS (OS) AND MITOCHONDRIAL ALTERATIONS HAVE BEEN IMPLICATED IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS (RA). VARIOUS ENVIRONMENTAL TRIGGERS LIKE AIR POLLUTANTS, SMOKING, UNHEALTHY SOCIAL HABITS AND SEDENTARY LIFESTYLE INDUCE OS, WHICH MAY COMPROMISE MITOCHONDRIAL INTEGRITY. THIS TRIAL WAS DESIGNED TO EXPLORE THE EFFECT OF 8-WEEKS YOGA PRACTICE ON MITOCHONDRIAL HEALTH AND DISEASE SEVERITY IN AN ACTIVE RA GROUP COMPARED WITH A USUAL-CARE CONTROL GROUP. METHODS: A TOTAL OF 70 SUBJECTS WERE RANDOMIZED INTO TWO GROUPS: YOGA GROUP AND NON-YOGA GROUP. MITOCHONDRIAL HEALTH WAS ASSESSED BY CALCULATION OF MITOCHONDRIAL DNA COPY NUMBER (MTDNA-CN), OS MARKERS, MITOCHONDRIAL ACTIVITY, MITOCHONDRIAL MEMBRANE POTENTIAL (DELTAPSIM), CIRCADIAN RHYTHM MARKERS AND TRANSCRIPTS ASSOCIATED WITH MITOCHONDRIAL INTEGRITY: AMPK, TIMP-1, KLOTHO, SIRT-1, AND TFAM. PARAMETERS OF DISEASE ACTIVITY AND DISABILITY QUOTIENT WERE ALSO ASSESSED BY DISEASE ACTIVITY SCORE - ERYTHROCYTE SEDIMENTATION RATE (DAS28-ESR) AND HEALTH ASSESSMENT QUESTIONNAIRE-DISABILITY INDEX (HAQ-DI), RESPECTIVELY. RESULTS: IN YOGA GROUP, THERE WAS A SIGNIFICANT UPREGULATION OF MTDNA-CN, MITOCHONDRIAL ACTIVITY MARKERS, DELTAPSIM, AND TRANSCRIPTS THAT MAINTAIN MITOCHONDRIAL INTEGRITY AFTER 8-WEEKS OF YOGA. THERE WAS OPTIMIZATION OF OS MARKERS, AND CIRCADIAN RHYTHM MARKERS POST 8-WEEKS PRACTICE OF YOGA. YOGA GROUP PARTICIPANTS SHOWED SIGNIFICANT IMPROVEMENTS IN DAS28-ESR (P < 0.05) AND HAQ-DI (P < 0.05) OVER THE NON-YOGA GROUP. CONCLUSION: ADOPTION OF YOGA BY RA PATIENTS HOLDS THE KEY TO ENHANCE MITOCHONDRIAL HEALTH, IMPROVE CIRCADIAN RHYTHM MARKERS, OS MARKER REGULATION, UPREGULATION OF TRANSCRIPTS THAT MAINTAIN MITOCHONDRIAL INTEGRITY, REDUCE DISEASE ACTIVITY AND ITS ASSOCIATED CONSEQUENCES ON HEALTH OUTCOME AND HENCE CAN BE BENEFICIAL AS AN ADJUNCT THERAPY. 2021 2 2490 21 YOGA AS AN INTERVENTION TO MANAGE MULTIPLE SCLEROSIS SYMPTOMS. MULTIPLE SCLEROSIS (MS) IS AN AUTOIMMUNE, DEMYELINATING, INFLAMMATORY DISEASE OF CENTRAL NERVOUS SYSTEM (CNS) WHICH IS CHARACTERIZED BY SPASTICITY, FATIGUE, DEPRESSION, ANXIETY, BOWEL AND BLADDER DYSFUNCTION, IMPAIRED MOBILITY, COGNITIVE IMPAIRMENT ETC. AND AFFECTS APPROXIMATELY 2.5 MILLION PEOPLE WORLDWIDE. DISEASE MODIFYING THERAPIES FOR MS WHICH HELP IN PREVENTING ACCUMULATION OF LESIONS IN WHITE MATTER OF CNS ARE COSTLY AND HAVE SIGNIFICANT ADVERSE EFFECTS. THEREFORE, PATIENTS WITH MS ARE USING COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) AND YOGA IS ONE OF THE MOST POPULAR FORM OF CAM WHICH IS BEING USED IMMENSELY TO REDUCE OR OVERCOME THE SYMPTOMS OF MS. IN THE CURRENT REVIEW ATTEMPTED TO PRESENT THE POTENTIAL IMPACT OF YOGA PRACTICES ON REDUCING MS RELATED SYMPTOMS. 2020 3 683 67 EFFECT OF AN 8-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON PSYCHO-NEURO-IMMUNE AXIS, DISEASE ACTIVITY, AND PERCEIVED QUALITY OF LIFE IN RHEUMATOID ARTHRITIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL. VARIOUS EXTERNAL STRESSORS AND ENVIRONMENTAL CHALLENGES LEAD TO THE PROVOCATION OF THE IMMUNE SYSTEM IN AUTOIMMUNE DISEASES LIKE RHEUMATOID ARTHRITIS (RA). THE INAPPROPRIATE IMMUNE RESPONSE FURTHER TRIGGERS THE CASCADE OF INFLAMMATORY CHANGES RESULTING IN PRECIPITATION OF SYMPTOMS AND HAMPERS QUALITY OF LIFE (QOL). THE UNDERLYING PSYCHO-SOMATIC COMPONENT OF THE DISEASE REQUIRES A HOLISTIC APPROACH TO ITS TREATMENT DIMENSION RATHER THAN THE USE OF PHARMACOTHERAPY. THE APPLICABILITY OF MIND-BODY INTERVENTIONS HAS BECOME ESSENTIAL IN TODAY'S FAST-PACED LIFE. YOGA, A MIND-BODY TECHNIQUE, ALTERS THE MIND'S CAPACITY TO FACILITATE SYSTEMIC FUNCTIONING AT MULTIPLE ORGAN SYSTEM LEVELS. HENCE, WE CONDUCTED THIS STUDY TO EVALUATE THE IMPACT OF 8 WEEKS OF A YOGA-BASED LIFESTYLE INTERVENTION (YBLI) ON PSYCHO-NEURO-IMMUNE MARKERS, GENE EXPRESSION PATTERNS, AND QOL IN RA PATIENTS ON ROUTINE MEDICAL THERAPY. A TOTAL OF 66 PATIENTS WERE RANDOMIZED INTO TWO GROUPS: YOGA GROUP OR NON-YOGA GROUP AND WERE ASSESSED FOR A PANEL OF INFLAMMATORY CYTOKINES (IL-6, IL-17A, TNF-ALPHA, AND TGF-BETA), MIND-BODY COMMUNICATIVE MARKERS (BDNF, DHEAS, BETA-ENDORPHIN, AND SIRTUIN) AND TRANSCRIPT LEVELS OF VARIOUS GENES (IL-6, TNF-ALPHA, NFKB1, TGF-BETA, AND CTLA4). WE ASSESSED DISEASE ACTIVITY AND QOL USING THE DAS28-ESR AND WHOQOL-BREF QUESTIONNAIRE, RESPECTIVELY. YOGA GROUP OBSERVED SIGNIFICANT IMPROVEMENTS IN THE LEVELS OF MARKERS, WHICH INFLUENCED THE PSYCHO-NEURO-IMMUNE AXIS (P < 0.001) WITH AN ESTIMATED EFFECT SIZE FROM SMALL TO MEDIUM RANGE. IN THE YOGA GROUP, THERE WAS A SIGNIFICANT REDUCTION IN DAS28-ESR (P < 0.001) AND IMPROVEMENT SEEN IN THE PHYSICAL HEALTH, PSYCHOLOGICAL, SOCIAL RELATIONSHIPS DOMAINS (P < 0.001) OF QOL, EXCEPT ENVIRONMENTAL (P > 0.05). THE YOGA GROUP SHOWED DOWNREGULATION OF IL-6, TNF-ALPHA, AND CTLA4 AND UPREGULATION OF TGF-BETA. THESE RESULTS SUGGEST THAT A DECREASE IN DISEASE ACTIVITY AFTER YOGA PRACTICE IS ASSOCIATED WITH A SIGNIFICANT REDUCTION IN INFLAMMATORY CYTOKINES, THE ELEVATION OF MIND-BODY COMMUNICATIVE MARKERS, AND NORMALIZATION OF VARIOUS TRANSCRIPT LEVELS, WHICH IMPROVED QOL. THUS THE ADOPTION OF YBLI IMPROVES CLINICAL OUTCOME IN RA, AND DECREASES SYSTEMIC INFLAMMATION BY ITS BENEFICIAL EFFECTS ON PSYCHO-NEURO-IMMUNE AXIS AND NORMALIZATION OF DYSREGULATED TRANSCRIPTS. THUS YBLI MAY BE USED FOR RA PATIENTS AS AN ADJUNCTIVE THERAPY. 2020 4 2412 35 YOGA AND ITS IMPACT ON CHRONIC INFLAMMATORY AUTOIMMUNE ARTHRITIS. RHEUMATOID ARTHRITIS (RA) IS ONE OF THE MOST COMMON CHRONIC INFLAMMATORY AUTOIMMUNE DISEASES, WHICH ADVERSELY AFFECTS THE QUALITY OF LIFE. RA IS A DISEASE OF UNKNOWN ETIOLOGY, HOWEVER, BOTH GENETIC AND ENVIRONMENTAL FACTORS APPEAR TO CONTRIBUTE TO THE SUSCEPTIBILITY TO THIS DISEASE. THE SEVERITY AND PROGRESSION OF THE DISEASE ARE ATTRIBUTABLE TO THE RELEASE OF A HOST OF INFLAMMATORY CYTOKINES, CYTOTOXIC AND IMMUNE REGULATORY FACTORS. THE TREATMENTS OF RA ARE PRIMARILY LIMITED TO SYMPTOMATIC ALLEVIATION OF PAIN OR OTHER SYMPTOMS OR TO THE USE OF CYTOTOXIC DRUG TREATMENT IN SEVERE FORMS OF THE DISEASE WHICH IS COMMONLY ASSOCIATED WITH SIGNIFICANT SIDE EFFECTS. DESPITE LACK OF A CURE, THE DISEASE MAY BE CONTROLLED BY MIND-BODY INTERVENTIONS. HOLISTIC TREATMENTS SUCH AS YOGA SIGNIFICANTLY IMPROVE AND REDUCE THE PSYCHO-SOMATIC SYMPTOMS, PAIN PERCEPTION, DISABILITY QUOTIENT, JOINT FLEXIBILITY, RANGE OF MOTION, POSTURE, MUSCLE STRENGTH, COORDINATION, AND DISEASE ACTIVITY. HERE, WE DISCUSS THE FEATURES OF RA AND ADDRESS HOW YOGA CAN BE USED AS A THERAPEUTIC REGIMEN TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH RA. 2021 5 2300 25 THERAPEUTIC YOGA: SYMPTOM MANAGEMENT FOR MULTIPLE SCLEROSIS. MULTIPLE SCLEROSIS (MS) IS THE MOST COMMON AUTOIMMUNE INFLAMMATORY DEMYELINATING DISEASE OF THE CENTRAL NERVOUS SYSTEM, AFFECTING OVER 2.3 MILLION PEOPLE WORLDWIDE. ACCORDING TO THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, THE AGE OF DISEASE ONSET IS TYPICALLY BETWEEN 20 AND 40 YEARS, WITH A HIGHER INCIDENCE IN WOMEN. INDIVIDUALS WITH MS EXPERIENCE A WIDE RANGE OF SYMPTOMS, INCLUDING DECLINING PHYSICAL, EMOTIONAL, AND PSYCHOLOGICAL SYMPTOMS (E.G., FATIGUE, IMBALANCE, SPASTICITY, CHRONIC PAIN, COGNITIVE IMPAIRMENT, BLADDER AND BOWEL DYSFUNCTION, VISUAL AND SPEECH IMPAIRMENTS, DEPRESSION, SENSORY DISTURBANCE, AND MOBILITY IMPAIRMENT). TO DATE, BOTH THE CAUSE OF AND CURE FOR MS REMAIN UNKNOWN. IN RECENT YEARS, MORE INDIVIDUALS WITH MS HAVE BEEN PURSUING ALTERNATIVE METHODS OF TREATMENT TO MANAGE SYMPTOMS OF THE DISEASE, INCLUDING MIND-BODY THERAPIES SUCH AS YOGA, MEDITATION, BREATHING, AND RELAXATION TECHNIQUES. IT HAS BEEN SUGGESTED THAT THE PRACTICE OF YOGA MAY BE A SAFE AND EFFECTIVE WAY OF MANAGING SYMPTOMS OF MS. THEREFORE, THE PURPOSE OF THIS PAPER IS TO SUMMARIZE THE MOST RELEVANT LITERATURE ON EXERCISE AND MIND-BODY MODALITIES TO TREAT MS SYMPTOMS AND, MORE SPECIFICALLY, THE BENEFITS AND POTENTIAL ROLE OF YOGA AS AN ALTERNATIVE TREATMENT OF SYMPTOM MANAGEMENT FOR INDIVIDUALS WITH MS. THE ARTICLE ALSO DISCUSSES FUTURE DIRECTIONS FOR RESEARCH. 2015 6 2635 38 YOGA FOR TREATING RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. PURPOSE: RHEUMATOID ARTHRITIS (RA) IS A PERVASIVE INFLAMMATORY AUTOIMMUNE DISEASE THAT SERIOUSLY IMPAIRS HUMAN HEALTH AND REQUIRES MORE EFFECTIVE NON-PHARMACOLOGIC TREATMENT APPROACHES. THIS STUDY AIMS TO SYSTEMATICALLY REVIEW AND EVALUATE THE EFFICACY OF YOGA FOR PATIENTS WITH RA. METHODS: MEDLINE (THROUGH PUBMED), COCHRANE LIBRARY, EMBASE (THROUGH SCOPUS), AND WEB OF SCIENCE DATABASE WERE SCREENED THROUGH FOR ARTICLES PUBLISHED UNTIL 20 JULY 2020. RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA IN PATIENTS WITH RA WERE INCLUDED. OUTCOMES MEASURES WERE PAIN, PHYSICAL FUNCTION, DISEASE ACTIVITY, INFLAMMATORY CYTOKINES, AND GRIP STRENGTH. FOR EACH OUTCOME, STANDARDIZED MEAN DIFFERENCES (SMD) AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. RESULT: TEN TRIALS INCLUDING 840 PATIENTS WITH RA AGED 30-70 YEARS WERE IDENTIFIED, WITH 86% FEMALE PARTICIPANTS. META-ANALYSIS REVEALED A STATISTICALLY SIGNIFICANT OVERALL EFFECT IN FAVOR OF YOGA FOR PHYSICAL FUNCTION (HAQ-DI) (5 RCTS; SMD = -0.32, 95% CI -0.58 TO -0.05, I (2) = 15%, P = 0.02), DISEASE ACTIVITY (DAS-28) (4 RCTS; SMD = -0.38, 95% CI -0.71 TO -0.06, I (2) = 41%, P = 0.02) AND GRIP STRENGTH (2 RCTS; SMD = 1.30, 95% CI 0.47-2.13, I (2) = 63%, P = 0.002). NO EFFECTS WERE FOUND FOR PAIN, TENDER JOINTS, SWOLLEN JOINTS COUNT OR INFLAMMATORY CYTOKINES (I.E., CRP, ESR, IL-6, AND TNF-ALPHA). SUMMARY: THE FINDINGS OF THIS META-ANALYSIS INDICATE THAT YOGA MAY BE BENEFICIAL FOR IMPROVING PHYSICAL FUNCTION, DISEASE ACTIVITY, AND GRIP STRENGTH IN PATIENTS WITH RA. HOWEVER, THE BALANCE OF EVIDENCE SHOWED THAT YOGA HAD NO SIGNIFICANT EFFECT IN IMPROVING PAIN, TENDER JOINTS, SWOLLEN JOINTS COUNT, AND INFLAMMATORY CYTOKINES IN PATIENTS SUFFERING FROM RA. CONSIDERING METHODOLOGICAL LIMITATIONS, SMALL SAMPLE SIZE, AND LOW-QUALITY, WE DRAW A VERY CAUTIOUS CONCLUSION IN THE RESULTS OF THE ESTIMATE OF THE EFFECT. HIGH-QUALITY AND LARGE-SCALE RCTS ARE URGENTLY NEEDED IN THE FUTURE, AND THE REAL RESULT MAY BE SUBSTANTIALLY DIFFERENT. 2020 7 2460 23 YOGA AS A METHOD OF SYMPTOM MANAGEMENT IN MULTIPLE SCLEROSIS. MULTIPLE SCLEROSIS (MS) IS AN IMMUNE-MEDIATED PROCESS IN WHICH THE BODY'S IMMUNE SYSTEM DAMAGES MYELIN IN THE CENTRAL NERVOUS SYSTEM (CNS). THE ONSET OF THIS DISORDER TYPICALLY OCCURS IN YOUNG ADULTS, AND IT IS MORE COMMON AMONG WOMEN. CURRENTLY, THERE IS NO CURE AND THE LONG-TERM DISEASE PROGRESSION MAKES SYMPTOMATIC MANAGEMENT CRITICAL FOR MAINTAINING QUALITY OF LIFE. SEVERAL PHARMACOTHERAPEUTIC AGENTS ARE APPROVED FOR TREATMENT, BUT MANY PATIENTS SEEK COMPLEMENTARY AND ALTERNATIVE INTERVENTIONS. REVIEWS HAVE BEEN CONDUCTED REGARDING BROAD TOPICS SUCH AS MINDFULNESS-BASED INTERVENTIONS FOR PEOPLE DIAGNOSED WITH MS AND THE IMPACT OF YOGA ON A RANGE OF NEUROLOGICAL DISORDERS. THE OBJECTIVE OF THE PRESENT REVIEW IS TO EXAMINE THE POTENTIAL BENEFITS OF YOGA FOR INDIVIDUALS WITH MS AND ADDRESS ITS USE IN MANAGING SYMPTOMS INCLUDING PAIN, MENTAL HEALTH, FATIGUE, SPASTICITY, BALANCE, BLADDER CONTROL, AND SEXUAL FUNCTION. 2015 8 1515 22 IS YOGA A SUITABLE TREATMENT FOR RHEUMATOID ARTHRITIS: CURRENT OPINION. WE REVIEWED PUBLISHED LITERATURE REGARDING THE USE OF YOGA FOR MANAGING RHEUMATOID ARTHRITIS TO DETERMINE WHETHER ADEQUATE EVIDENCE EXISTS TO SUGGEST ITS USEFULNESS AS A THERAPY. A SEARCH FOR PREVIOUS STUDIES INVOLVING YOGA AND RHEUMATOID ARTHRITIS IN PUBMED YIELDED EIGHT REPORTS. THESE STUDIES REPORTED THE BENEFITS OF YOGA IN THE PHYSICAL AND MENTAL HEALTH OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA), SUGGESTING THAT YOGA IS A USEFUL ADD-ON THERAPY FOR RA PATIENTS. HOWEVER, ALL STUDIES SHOWED LIMITATIONS WITH RESPECT TO SAMPLE SIZE, STUDY DESIGN, DESCRIPTION AND DURATION OF YOGA INTERVENTION, AND ASSESSMENT TOOLS AND STATISTICAL METHODS USED. ADDITIONALLY, THE STUDIES DID NOT ATTEMPT TO UNDERSTAND THE MECHANISMS UNDERLYING OBSERVED BENEFITS. HENCE, EVIDENCE SUGGESTS A DEFINITE ROLE OF YOGA IN RA IMPROVEMENT, REDUCING PAIN, IMPROVING FUNCTION, AND CREATING A POSITIVE MENTAL STATE. HOWEVER, DETAILED ANALYSIS AND ADDITIONAL STUDIES ARE NECESSARY TO VERIFY THESE OBSERVATIONS. 2012 9 2516 15 YOGA CLINICAL RESEARCH REVIEW. IN THIS PAPER RECENT RESEARCH IS REVIEWED ON THE EFFECTS OF YOGA POSES ON PSYCHOLOGICAL CONDITIONS INCLUDING ANXIETY AND DEPRESSION, ON PAIN SYNDROMES, CARDIOVASCULAR, AUTOIMMUNE AND IMMUNE CONDITIONS AND ON PREGNANCY. FURTHER, THE PHYSIOLOGICAL EFFECTS OF YOGA INCLUDING DECREASED HEARTRATE AND BLOOD PRESSURE AND THE PHYSICAL EFFECTS INCLUDING WEIGHT LOSS AND INCREASED MUSCLE STRENGTH ARE REVIEWED. FINALLY, POTENTIAL UNDERLYING MECHANISMS ARE PROPOSED INCLUDING THE STIMULATION OF PRESSURE RECEPTORS LEADING TO ENHANCED VAGAL ACTIVITY AND REDUCED CORTISOL. THE REDUCTION IN CORTISOL, IN TURN, MAY CONTRIBUTE TO POSITIVE EFFECTS SUCH AS ENHANCED IMMUNE FUNCTION AND A LOWER PREMATURITY RATE. 2011 10 2783 32 YOGA THERAPY AS AN ADJUNCT TO CONVENTIONAL MANAGEMENT OF SYSTEMIC SCLEROSIS: A CASE SERIES. SYSTEMIC SCLEROSIS (SSC) IS AN AUTOIMMUNE DISORDER LEADING TO SIGNIFICANT DISABILITY AND LOSS OF QUALITY OF LIFE (QOL). YOGA HAS BECOME POPULAR IN RECENT TIMES FOR ITS POTENTIAL THERAPEUTIC BENEFITS. SINCE THERE ARE NO SCIENTIFIC REPORTS ON THE USE OF YOGA FOR SSC, WE PRESENT TWO FEMALE CASES (AGED 49 AND 29 RESPECTIVELY) OF LIMITED SSC (DURATION OF ILLNESS 4 AND 3 YEARS RESPECTIVELY) WHO UNDERWENT YOGA THERAPY AS AN ADJUNCT TO CONVENTIONAL MANAGEMENT IN A RESIDENTIAL SETTING FOR A PERIOD OF FIVE AND FOUR WEEKS, RESPECTIVELY. DURING THEIR STAY, THEY UNDERWENT A SPECIFICALLY DESIGNED YOGA MODULE. AFTER THEIR DISCHARGE, THEY WERE FOLLOWED-UP FOR FOUR WEEKS, DURING WHICH THEY WERE ASKED TO CONTINUE PRACTICING YOGA FOR 1 H EVERY DAY. BOTH OF THEM REPORTED A REDUCTION IN PAIN, STIFFNESS, SYMPTOM SCORES, AND IMPROVED QOL ON DISCHARGE AND AT THE FOLLOW-UP COMPARED TO THE VALUES ON ADMISSION. ERYTHROCYTE SEDIMENTATION RATE (ESR) AND C-REACTIVE PROTEIN (CRP), AS BIOMARKERS OF INFLAMMATION, REDUCED ON THE DISCHARGE WHEN COMPARED TO THE BASELINE. NO ADVERSE EVENTS WERE NOTED DURING THE STAY AND THE FOLLOW-UP. THUS, THE PRESENT CASE SERIES INDICATE A POSSIBLE BENEFICIAL ROLE OF YOGA AS AN ADJUNCT THERAPY TO CONVENTIONAL MANAGEMENT OF SSC. FURTHER STUDIES IN THE AREA ARE WARRANTED TO ASCERTAIN THE EFFICACY OF YOGA FOR SSC. 2021 11 2079 31 THE EFFECT OF EXERCISE, YOGA AND PHYSIOTHERAPY ON THE QUALITY OF LIFE OF PEOPLE WITH MULTIPLE SCLEROSIS: SYSTEMATIC REVIEW AND META-ANALYSIS. INTRODUCTION: MULTIPLE SCLEROSIS (MS) IS A CHRONIC AUTOIMMUNE DISEASE AFFECTING THE MYELINATED AXONS OF THE CENTRAL NERVOUS SYSTEM CAUSING NEUROLOGICAL DETERIORATION. PEOPLE LIVING WITH MS HAVE A POOR QUALITY OF LIFE (QOL) BECAUSE OF THE SYMPTOMS CAUSED BY THE DISEASE AND THERE ARE VARIOUS TYPES OF TREATMENTS TO MANAGE THE SYMPTOMS ASIDE FROM MEDICATION. OBJECTIVE: THIS META-ANALYSIS EXAMINES THE EFFECT OF EXERCISE, YOGA AND PHYSIOTHERAPY ON THE PHYSICAL, MENTAL AND SOCIAL QOL AMONG INDIVIDUALS LIVING WITH MS. SETTING: A SYSTEMATIC REVIEW WITH META-ANALYSIS WAS CONDUCTED USING PUBMED, MEDLINE, AND SCOPUS FROM 1990 TO 2017. THE STANDARD MEAN DIFFERENCE SCORES WERE COMPUTED IN EACH STUDY FOR THE DOMAINS OF PHYSICAL, MENTAL AND SOCIAL FUNCTIONING. RESULTS: EIGHTEEN STUDIES MET THE INCLUSION CRITERIA FOR THIS META-ANALYSIS. AEROBIC EXERCISE WAS EFFECTIVE IN IMPROVING SATISFACTION WITH PHYSICAL FUNCTIONING,D = 0.35 (95% CI = 0.08 TO 0.62), MENTAL FUNCTIONING D = 0.42 (95% CI = 0.11 TO 0.72), AND SOCIAL FUNCTIONING D = 0.42 (95% CI = 0.15 TO 0.69). PHYSIOTHERAPY WAS ALSO FOUND TO BE EFFECTIVE FOR PHYSICAL FUNCTIONING D = 0.50 (95% CI 0.19 TO 0.80), MENTAL FUNCTIONING D = 0.44 (95% CI 0.14 TO 0.75) AND SOCIAL FUNCTIONING D = 0.60 (95% CI 0.21 TO 0.90). HOWEVER YOGA AND COMBINATION OF EXERCISES DID NOT HAVE A SIGNIFICANT EFFECT ON ANY OF THE QOL DOMAINS. CONCLUSION: THESE FINDINGS SUGGEST THAT AEROBIC EXERCISE AND PHYSIOTHERAPY IMPROVES THE SATISFACTION OF MS PATIENTS WITH THEIR PHYSICAL, MENTAL AND SOCIAL FUNCTIONING AND MAY BE INCLUDED AS NORMAL PRACTICE IN THE TREATMENT OF MS. 2019 12 2026 22 TAI CHI AND YOGA AS COMPLEMENTARY THERAPIES IN RHEUMATOLOGIC CONDITIONS. TAI CHI AND YOGA ARE COMPLEMENTARY THERAPIES WHICH HAVE, DURING THE LAST FEW DECADES, EMERGED AS POPULAR TREATMENTS FOR RHEUMATOLOGIC AND MUSCULOSKELETAL DISEASES. THIS REVIEW COVERS THE EVIDENCE OF TAI CHI AND YOGA IN THE MANAGEMENT OF RHEUMATOLOGIC DISEASES, ESPECIALLY OSTEOARTHRITIS OF THE KNEE, HIP AND HAND, AND RHEUMATOID ARTHRITIS. THERE IS EVIDENCE THAT TAI CHI AND YOGA ARE SAFE, AND SOME EVIDENCE THAT THEY HAVE BENEFIT, LEADING TO REDUCTION OF PAIN AND IMPROVEMENT OF PHYSICAL FUNCTION AND QUALITY OF LIFE IN PATIENTS. RECOMMENDATIONS FOR TAI CHI IN KNEE OSTEOARTHRITIS HAVE RECENTLY BEEN ISSUED BY THE AMERICAN COLLEGE OF RHEUMATOLOGY. TO ALLOW BROADER RECOMMENDATIONS FOR THE USE OF TAI CHI AND YOGA IN RHEUMATIC DISEASES, THERE IS A NEED TO COLLECT MORE EVIDENCE RESEARCHED WITH LARGER RANDOMISED CONTROLLED TRIALS. 2012 13 1395 69 IMPACT OF YOGA BASED MIND-BODY INTERVENTION ON SYSTEMIC INFLAMMATORY MARKERS AND CO-MORBID DEPRESSION IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: RECOVERY OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) DEPENDS ON SEVERAL PHYSICAL AND PSYCHOLOGICAL FACTORS, BESIDES PHARMACOLOGICAL TREATMENT. CO-MORBID DEPRESSION ADVERSELY AFFECTS THE OUTCOME IN RA. USUAL MEDICAL THERAPIES HAVE A LIMITED SCOPE AND FAIL TO CURE THE PSYCHOLOGICAL COMPONENT OF THE DISEASE. WITH ADVANCED THERAPEUTIC OPTIONS, ACHIEVING A STATE OF REMISSION HAS BECOME THE TREATMENT GOAL, YOGA BASED MIND BODY INTERVENTION (MBI) MAY PROVIDE A HOLISTIC APPROACH IN ITS TREATMENT DIMENSION. HENCE, MBIS ARE THE NEED OF HOUR AS MAJORITY OF DISEASES HAVE A PSYCHOSOMATIC COMPONENT. OBJECTIVE: TO EXPLORE THE EFFECT OF YOGA BASED MBI ON DISEASE SPECIFIC INFLAMMATORY MARKERS AND DEPRESSION SEVERITY IN ACTIVE RA PATIENTS ON ROUTINE DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS) THERAPY. METHODS: A TOTAL OF 72 RA PATIENTS WERE RANDOMIZED INTO 2 GROUPS: YOGA GROUP (YOGA WITH DMARDS) AND CONTROL GROUP (DMARDS ONLY). BLOOD SAMPLES WERE COLLECTED PRE AND POST INTERVENTION FOR PRIMARY OUTCOME MEASUREMENTS OF SYSTEMIC BIOMARKERS. DISEASE ACTIVITY SCORE 28, ERYTHROCYTE SEDIMENTATION RATE (DAS28ESR) AND HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX (HAQ-DI) WERE USED TO ASSESS DISEASE ACTIVITY AND FUNCTIONAL STATUS RESPECTIVELY AT PRE AND POST INTERVENTION TIME-POINTS. SECONDARY OUTCOME, DEPRESSION SEVERITY, WAS ASSESSED BY BECK DEPRESSION INVENTORY II SCALE (BDI-II) AT 2 WEEKLY INTERVALS DURING 8 WEEKS OF THE STUDY INTERVENTIONAL PLAN. RESULTS: AFTER 8 WEEKS OF YOGA BASED MBI, THERE WAS SIGNIFICANT DECREASE IN THE SEVERITY OF RA AS SEEN BY REDUCTION IN LEVELS OF VARIOUS SYSTEMIC INFLAMMATORY MARKERS AS WELL AS IN DAS28ESR (P-VALUE <0.0001; EFFECT SIZE = 0.210) AND HAQ-DI (P-VALUE 0.001; EFFECT SIZE = 0.159). ALSO, YOGA GROUP EXPERIENCED A STATISTICALLY SIGNIFICANT TIME DEPENDENT STEP-WISE DECLINE IN DEPRESSION SYMPTOMS OVER THE PERIOD OF 8 WEEKS AS COMPARED TO CONTROL GROUP (P-VALUE <0.0001; EFFECT SIZE = 0.5). REGRESSION ANALYSIS SHOWED GREATER REDUCTION IN THE SCORES OF BDI-II WITH DAS28ESR (R2 = 0.426; P < 0.0001) AND HAQ-DI (R2 = 0.236; P = 0.003) IN YOGA GROUP. CONCLUSIONS: YOGA, A MIND BODY INTERVENTION RE-ESTABLISHED IMMUNOLOGICAL TOLERANCE BY AIDING REMISSION AT MOLECULAR AND CELLULAR LEVEL ALONG WITH SIGNIFICANT REDUCTION IN DEPRESSION. THUS IN THIS SEVERE AUTOIMMUNE INFLAMMATORY ARTHRITIS WITH A MAJOR PSYCHOSOMATIC COMPONENT, YOGA CAN BE USED AS A COMPLEMENTARY/ADJUNCT THERAPY. 2019 14 2774 32 YOGA RESEARCH REVIEW. THIS PAPER IS A REVIEW OF EMPIRICAL STUDIES, REVIEW AND META-ANALYSIS PUBLICATIONS ON YOGA FROM THE LAST FEW YEARS. THE REVIEW INCLUDES DEMOGRAPHICS/PREVALENCE OF YOGA AS A PRACTICE, BIBLIOMETRIC ANALYSES OF THE YOGA PUBLICATIONS AND THE USE OF YOGA FOR PHYSICAL FITNESS AND COGNITIVE FUNCTION. MOST OF THE STUDIES REVIEWED HERE INVOLVE YOGA EFFECTS ON PSYCHIATRIC AND MEDICAL CONDITIONS. THESE INCLUDE PREGNANCY, PRENATAL AND POSTPARTUM DEPRESSION; STRESS, PTSD, ANXIETY, AND OBESITY; CARDIOVASCULAR CONDITIONS INCLUDING HYPERTENSION; PAIN SYNDROMES INCLUDING ARTHRITIS, HEADACHES AND LOW BACK PAIN; AUTOIMMUNE CONDITIONS INCLUDING ASTHMA, TYPE II DIABETES AND MULTIPLE SCLEROSIS; IMMUNE CONDITIONS INCLUDING HIV AND BREAST CANCER; AND AGING PROBLEMS INCLUDING BALANCE, OSTEOPOROSIS AND PARKINSON'S. THE METHODS AND RESULTS OF THOSE STUDIES ARE BRIEFLY SUMMARIZED ALONG WITH THEIR LIMITATIONS AND SUGGESTIONS FOR FUTURE RESEARCH. BASICALLY YOGA HAS BEEN MORE EFFECTIVE THAN CONTROL AND WAITLIST CONTROL CONDITIONS, ALTHOUGH NOT ALWAYS MORE EFFECTIVE THAN TREATMENT COMPARISON GROUPS SUCH AS OTHER FORMS OF EXERCISE. MORE RANDOMIZED CONTROLLED STUDIES ARE NEEDED IN WHICH YOGA IS COMPARED TO ACTIVE EXERCISE GROUPS. HAVING ESTABLISHED THE PHYSICAL AND MENTAL HEALTH BENEFITS OF YOGA MAKES IT ETHICALLY QUESTIONABLE TO ASSIGN PARTICIPANTS TO INACTIVE CONTROL GROUPS. SHORTER SESSIONS SHOULD BE INVESTIGATED FOR COST-EFFECTIVENESS AND FOR DAILY PRACTICE. MULTIPLE PHYSICAL AND PHYSIOLOGICAL MEASURES NEED TO BE ADDED TO THE SELF-REPORT RESEARCH PROTOCOLS AND POTENTIAL UNDERLYING MECHANISMS NEED TO BE FURTHER EXPLORED. IN THE INTERIM, THE STUDIES REVIEWED HERE HIGHLIGHT THE THERAPEUTIC EFFECTS OF YOGA, A PRACTICE THAT COULD COME TO BE CALLED YOGA THERAPY. 2016 15 1640 34 MOLECULAR SIGNATURE OF THE IMMUNE RESPONSE TO YOGA THERAPY IN STRESS-RELATED CHRONIC DISEASE CONDITIONS: AN INSIGHT. THE WORLD HEALTH ORGANIZATION DEFINES HEALTH AS COMPLETE WELL-BEING IN TERMS OF PHYSICAL, MENTAL AND SOCIAL, AND NOT MERELY THE ABSENCE OF DISEASE. TO ATTAIN THIS, INDIVIDUAL SHOULD ADAPT AND SELF-MANGE THE SOCIAL, PHYSICAL AND EMOTIONAL CHALLENGES OF LIFE. EXPOSURE TO CHRONIC STRESS DUE TO URBANIZATION, WORK STRESS, NUCLEAR FAMILY, POLLUTION, UNHEALTHY FOOD HABITS, LIFESTYLE, ACCIDENTAL DEATH IN THE FAMILY, AND NATURAL CALAMITIES ARE THE TRIGGERING FACTORS, LEADING TO HORMONAL IMBALANCE AND INFLAMMATION IN THE TISSUE. THE RELATIONSHIP BETWEEN STRESS AND ILLNESS IS COMPLEX; ALL CHRONIC ILLNESSES SUCH AS CARDIOVASCULAR DISEASE AND ASTHMA HAVE THEIR ROOT IN CHRONIC STRESS ATTRIBUTED BY INFLAMMATION. IN RECENT TIMES, YOGA THERAPY HAS EMERGED AS AN IMPORTANT COMPLEMENTARY ALTERNATIVE MEDICINE FOR MANY HUMAN DISEASES. YOGA THERAPY HAS A POSITIVE IMPACT ON MIND AND BODY; IT ACTS BY INCORPORATING APPROPRIATE BREATHING TECHNIQUES AND MINDFULNESS TO ATTAIN CONSCIOUS DIRECTION OF OUR AWARENESS OF THE PRESENT MOMENT BY MEDITATION, WHICH HELPS ACHIEVE HARMONY BETWEEN THE BODY AND MIND. STUDIES HAVE ALSO DEMONSTRATED THE IMPORTANT REGULATORY EFFECTS OF YOGA THERAPY ON BRAIN STRUCTURE AND FUNCTIONS. DESPITE THESE ADVANCES, THE CELLULAR AND MOLECULAR MECHANISMS BY WHICH YOGA THERAPY RENDERS ITS BENEFICIAL EFFECTS ARE INADEQUATELY KNOWN. A GROWING BODY OF EVIDENCE SUGGESTS THAT YOGA THERAPY HAS IMMUNOMODULATORY EFFECTS. HOWEVER, THE PRECISE MECHANISTIC BASIS HAS NOT BEEN ADDRESSED EMPIRICALLY. IN THIS REVIEW, WE HAVE ATTEMPTED TO HIGHLIGHT THE EFFECT OF YOGA THERAPY ON IMMUNE SYSTEM FUNCTIONING WITH AN AIM TO IDENTIFY IMPORTANT IMMUNOLOGICAL SIGNATURES THAT INDEX THE EFFECT OF YOGA THERAPY. TOWARD THIS, WE HAVE SUMMARIZED THE AVAILABLE SCIENTIFIC EVIDENCE SHOWING POSITIVE IMPACTS OF YOGA THERAPY. FINALLY, WE HAVE EMPHASIZED THE EFFICACY OF YOGA IN IMPROVING PHYSICAL AND MENTAL WELL-BEING. YOGA HAS BEEN A PART OF INDIAN CULTURE AND TRADITION FOR LONG; NOW, THE TIME HAS COME TO SCIENTIFICALLY VALIDATE THIS AND IMPLEMENT THIS AS AN ALTERNATIVE TREATMENT METHOD FOR STRESS-RELATED CHRONIC DISEASE. 2020 16 1771 39 POTENTIAL ROLE OF YOGA IN THE MANAGEMENT OF ANKYLOSING SPONDYLITIS: A RETROSPECTIVE STUDY. BACKGROUND: ANKYLOSING SPONDYLITIS (AS) IS A CHRONIC AUTOIMMUNE INFLAMMATORY SPONDYLOARTHROPATHY WITH UNCLEAR PATHOGENESIS. THE INFLAMMATORY PAIN IN AS LEADS TO RESTRICTED SPINAL MOBILITY AND SIGNIFICANT DISABILITY. YOGA IS A NONPHARMACOLOGICAL INTERVENTION THAT HAS POSITIVE EFFECTS ON VARIOUS MUSCULOSKELETAL-RELATED PROBLEMS. HOWEVER, ITS ROLE IN AS IS UNKNOWN. OBJECTIVE: THE PRESENT RETROSPECTIVE STUDY ASSESSED THE EFFICACY OF A TWO-WEEK RESIDENTIAL YOGA INTERVENTION ON SPINAL FLEXIBILITY AMONG AS PATIENTS. METHODS: THE RECORDS FOR 24 MALE AS PATIENTS WITHIN THE AGE RANGE 30 TO 50 YEARS (AVERAGE AGE 38.3 +/- 10.5 YEARS) WHO UNDERWENT A TWO-WEEK RESIDENTIAL YOGA RETREAT BETWEEN 2015 AND 2020 WERE OBTAINED FROM A YOGA CENTER LOCATED IN SOUTH INDIA. YOGA INTERVENTION CONSISTED OF YOGA POSTURES, BREATHING PRACTICES, MEDITATION, A HEALTHY DIET, AND DEVOTIONAL SESSIONS. PRE AND POST DATA OF THE SIT-AND-REACH TEST, BLOOD PRESSURE, HEART RATE, AND SYMPTOM SCORE WERE ANALYZED USING STATISTICAL PACKAGE FOR SOCIAL SCIENCES (SPSS). RESULTS: COMPARED TO THE BASELINE, THE POST SCORES OF THE SIT-AND-REACH TEST, SYSTOLIC BLOOD PRESSURE AND HEART RATE WERE FOUND TO BE SIGNIFICANTLY (P < .05) LOWER. THE SYMPTOM SCORE AND ANALGESIC MEDICATION SCORE ALSO SHOWED SIGNIFICANT IMPROVEMENT AFTER TWO-WEEKS COMPARED TO THE BASELINE. CONCLUSION: THIS RETROSPECTIVE STUDY INDICATES THE POSITIVE IMPACT OF ON AND ANALGESIC USE AMONG AS PATIENTS. HOWEVER, ADDITIONAL STUDIES USING ROBUST RESEARCH DESIGNS ARE WARRANTED. 2021 17 2454 24 YOGA AS A COMPLEMENTARY THERAPY FOR METABOLIC SYNDROME: A NARRATIVE REVIEW. METABOLIC SYNDROME (MS) IS ASSOCIATED WITH A SEDENTARY AND STRESSFUL LIFESTYLE AND AFFECTS UNDERACTIVE PEOPLE DISPROPORTIONATELY. YOGA IS CONSIDERED TO BE A LOW-IMPACT MIND-BODY STRESS-RELIEVING EXERCISE, AND RESEARCHERS ARE INCREASING THEIR FOCUS ON THE BENEFITS OF YOGA FOR MANAGING METABOLIC DISORDERS. IT IS ALSO IMPORTANT FOR PHYSICIANS AND HEALTH CARE PROFESSIONALS TO UNDERSTAND THE THERAPEUTIC EFFICACY OF YOGA INTERVENTION, IN TERMS OF ITS TYPE, DURATION AND FREQUENCY ON VARIOUS MS RISK FACTORS. THE PRESENT REVIEW SUMMARIZES THE CURRENT SCIENTIFIC UNDERSTANDING OF THE EFFECTS OF YOGA ON MS RISK FACTORS SUCH AS GLUCOSE HOMEOSTASIS MARKERS, LIPID PROFILE, ADIPOCYTOKINES AND CARDIOVASCULAR RISK FACTORS, AND DISCUSSES THE POSSIBLE MECHANISMS OF ACTION. MEDLINE, PUBMED, SCOPUS AND COCHRANE LIBRARY WERE SEARCHED FROM THEIR INCEPTION UP TO DECEMBER 2019, USING THE KEYWORDS "METABOLIC SYNDROME," "DIABETES," "CARDIOVASCULAR DISEASES," "OBESITY" AND "YOGA." THE LITERATURE SUMMARIZED IN THIS REVIEW HAVE SHOWN MIXED EFFECTS OF YOGA ON MS RISK FACTORS AND DO NOT PROVIDE ROBUST EVIDENCE FOR ITS EFFICACY. MORE RIGOROUS RESEARCH AND WELL-DESIGNED TRIALS THAT HAVE A HIGHER STANDARD OF METHODOLOGY AND EVALUATE YOGA'S LONG-TERM IMPACTS ON MS ARE NEEDED. UNDERSTANDING YOGA'S BIOCHEMICAL AND MOLECULAR MECHANISMS OF ACTION ON VARIOUS METABOLIC PATHWAYS IS ALSO NEEDED. 2021 18 1035 27 EFFECTS OF YOGA IN INFLAMMATORY BOWEL DISEASES AND ON FREQUENT IBD-ASSOCIATED EXTRAINTESTINAL SYMPTOMS LIKE FATIGUE AND DEPRESSION. QUALITY OF LIFE (QOL) OF PERSONS WITH INFLAMMATORY BOWEL DISEASES (IBD) IS OFTEN IMPAIRED BY SYMPTOMS THAT DO NOT PRIMARILY RELATE TO INTESTINAL INFLAMMATION. AMONG THE MOST CHALLENGING EXTRAINTESTINAL SYMPTOMS ARE DEPRESSION AND FATIGUE, WHICH ARE ALSO FREQUENT IN OTHER CHRONIC DISEASES LIKE MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND CANCER. YOGA AS AN ANCIENT INDIAN TRADITION CONTAINING POSTURES, BREATHING EXERCISES AND MEDITATION MAY POSITIVELY INFLUENCE THOSE SYMPTOMS. THIS REVIEW EVALUATES THE CURRENT LITERATURE WITH REGARD TO THE EFFECT OF YOGA-BASED INTERVENTIONS IN PERSONS WITH IBD AND WITH REGARD TO QOL, DEPRESSION AND FATIGUE IN OTHER SOMATIC DISORDERS. A SYSTEMATIC LITERATURE SEARCH YIELDED THREE TRIALS EXAMINING THE EFFECTS OF YOGA IN PATIENTS WITH IBD AND 37 TRIALS ADDRESSING DEPRESSIVE SYNDROMES OR FATIGUE IN SOMATIC DISORDERS. IN SUMMARY, BOTH IN-PERSON AND VIDEO-BASED YOGA CLASSES ARE FEASIBLE, ACCEPTABLE AND SAFE AS COMPLEMENTARY TREATMENT IN PATIENTS WITH IBD AND SIGNIFICANTLY IMPROVE ANXIETY AND IMPAIRED QUALITY OF LIFE. CURRENT LITERATURE DOES NOT PROVIDE INFORMATION ON THE EFFECT OF YOGA ON DEPRESSION AND FATIGUE IN PATIENTS WITH IBD, BUT RESEARCH FROM OTHER SOMATIC DISORDERS OR PATIENTS WITH DEPRESSIVE DISORDERS IMPLIES THE POTENTIAL OF YOGA IN THIS REGARD FOR PERSONS WITH IBD. THIS SHOULD BE SPECIFICALLY ADDRESSED IN INTERVENTIONAL TRIALS WITH STANDARDIZED YOGA MODULES INCLUDING PATIENTS WITH IBD SUFFERING FROM FATIGUE, DEPRESSION AND/OR IMPAIRED QOL. 2021 19 1927 25 ROLE OF YOGA IN CARDIAC DISEASE AND REHABILITATION. PURPOSE: CARDIOVASCULAR DISEASE CONTINUES TO BE THE LEADING CAUSE OF MORBIDITY AND MORTALITY AROUND THE WORLD. YOGA, A COMBINATION OF PHYSICAL POSTURES (ASANA), BREATHING EXERCISES (PRANAYAMA), AND MEDITATION (DHYANA), HAS GAINED INCREASING RECOGNITION AS A FORM OF MIND-BODY EXERCISE. IN THIS NARRATIVE REVIEW, WE INTENDED TO REVIEW THE EMERGING EVIDENCE ASSESSING THE PHYSIOLOGIC AND CLINICAL EFFECTS OF YOGA ON THE CARDIOVASCULAR SYSTEM AND THE POTENTIAL ROLE OF YOGA AS A COMPONENT OF COMPREHENSIVE CARDIAC REHABILITATION. METHODS: WE SEARCHED PUBMED, GOOGLE SCHOLAR, EMBASE, AND COCHRANE DATABASES FOR LITERATURE RELATED TO CARDIOVASCULAR EFFECTS OF YOGA FROM INCEPTION UP UNTIL 2017. RESULTS: YOGA HAS BEEN SHOWN TO HAVE FAVORABLE EFFECTS ON SYSTEMIC INFLAMMATION, STRESS, THE CARDIAC AUTONOMIC NERVOUS SYSTEM, AND TRADITIONAL AND EMERGING CARDIOVASCULAR RISK FACTORS. CONCLUSIONS: YOGA HAS SHOWN PROMISE AS A USEFUL LIFESTYLE INTERVENTION THAT CAN BE INCORPORATED INTO CARDIOVASCULAR DISEASE MANAGEMENT ALGORITHMS. ALTHOUGH MANY INVESTIGATORS HAVE REPORTED THE CLINICAL BENEFITS OF YOGA IN REDUCING CARDIOVASCULAR EVENTS, MORBIDITY, AND MORTALITY, EVIDENCE SUPPORTING THESE CONCLUSIONS IS SOMEWHAT LIMITED, THEREBY EMPHASIZING THE NEED FOR LARGE, WELL-DESIGNED RANDOMIZED TRIALS THAT MINIMIZE BIAS AND METHODOLOGICAL DRAWBACKS. 2019 20 61 36 A COMPREHENSIVE REVIEW OF YOGA RESEARCH IN 2020. OBJECTIVES: ACCUMULATED EVIDENCE GARNERED IN THE LAST FEW DECADES HAS HIGHLIGHTED THE ROLE OF YOGA IN HEALTH AND DISEASE. THE OVERWHELMING MORTALITY AND MORBIDITY MEDIATED BY NONCOMMUNICABLE EPIDEMICS SUCH AS HEART DISEASE AND CANCER HAVE FOSTERED A SEARCH FOR MECHANISMS TO ATTENUATE THEM. DESPITE OVERWHELMING SUCCESS IN ACUTE CARE, THE EFFICACY OF MODERN MEDICINES HAS BEEN LIMITED ON THIS FRONT. YOGA IS ONE OF THE INTEGRATIVE THERAPIES THAT HAS COME TO LIGHT AS HAVING A SUBSTANTIAL ROLE IN PREVENTING AND MITIGATING SUCH DISORDERS. IT THUS SEEMS TRITE TO ANALYZE AND DISCUSS THE RESEARCH ADVANCEMENTS IN YOGA FOR 2020. THE PRESENT REVIEW ATTEMPTS TO DISTILL RECENT RESEARCH HIGHLIGHTS FROM VOLUMINOUS LITERATURE GENERATED IN 2020. METHODS: THIS REVIEW WAS CONDUCTED ON THE ARTICLES PUBLISHED OR ASSIGNED TO AN ISSUE IN 2020. THE AUTHORS SEARCHED THE PUBMED DATABASE FOR CLINICAL STUDIES PUBLISHED IN THE ENGLISH LANGUAGE, USING YOGA (INCLUDING MEDITATION) AS THE INTERVENTION, AND HAVING AN ADEQUATE DESCRIPTION OF THE INTERVENTION. THEN, THEY EXTRACTED DATA FROM EACH STUDY INTO A STANDARDIZED GOOGLE SHEET. RESULTS: A TOTAL OF 1149 CITATIONS WERE RETRIEVED IN THE INITIAL SEARCH. OF THESE, 46 STUDIES MET ELIGIBILITY CRITERIA AND WERE FINALLY INCLUDED. THE STUDIES WERE PREDOMINANTLY ON MENTAL HEALTH AND NEUROPSYCHOLOGY, ADDRESSING VARIOUS ISSUES SUCH AS ANXIETY, POSTURAL BALANCE, MIGRAINE, ACADEMIC PERFORMANCE, AND CHILDHOOD NEGLECT. ANXIETY, STRESS, AND DEPRESSION WERE OTHER COMMON DENOMINATORS. EIGHT STUDIES WERE ON CARDIORESPIRATORY SYSTEMS, INCLUDING EXERCISE CAPACITY, CARDIAC REHABILITATION, MYOCARDIAL INFARCTION, AND HYPERTENSION. THREE STUDIES WERE ON DIABETES, EVALUATING THE EFFECT OF YOGA. FIVE STUDIES FOCUSED ON COGNITION, HEALTH STATUS, AND AUTONOMIC REGULATION AND FEW OTHERS INCLUDED CANCERS, INFERTILITY, ULCERATIVE COLITIS, URINARY INCONTINENCE, RESTLESS LEG SYNDROME, RHEUMATOID ARTHRITIS, CHRONIC PAIN, AND METABOLIC SYNDROME. FINALLY, MOST STUDIES WERE ON NONCOMMUNICABLE DISEASES WITH ONE EXCEPTION, HUMAN IMMUNODEFICIENCY VIRUS; TWO RANDOMIZED CONTROLLED TRIALS WERE DEDICATED TO IT. CONCLUSIONS: YOGA HAS BEEN STUDIED UNDER A WIDE VARIETY OF CLINICOPATHOLOGICAL CONDITIONS IN THE YEAR 2020. THIS LANDSCAPE REVIEW INTENDS TO PROVIDE AN IDEA OF THE ROLE OF YOGA IN VARIOUS CLINICAL CONDITIONS AND ITS FUTURE THERAPEUTIC IMPLICATIONS. 2022